Pedro Chorão

22PUBLICATIONS
95CO-AUTHORS
OtorhinolaryngologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Mar 27, 2026
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT.

Simone Cesaro, Chiara Garonzi, Gloria Tridello

|Mar 25, 2026
Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.

Urbain Tauveron-Jalenques, Gaspar Aspas Requena, Zofia Gross

|Jan 12, 2026
Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients: An Observational Retrospective Study.

Clara Isabel Martínez-López, Pedro Chorão, Ariadna Pérez

|Dec 30, 2025
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia.

Alejandro Segura Tudela, Ron Geller, Bruno Paiva

|Nov 18, 2025
Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study.

Lorenzo Lazzari, Aitana Balaguer-Roselló, Alessandro Bruno

Pageof 4

Frequent Collaborators

10 joint publications

Juan Montoro

9 joint publications

José Luis Piñana

6 joint publications

Manuel Guerreiro

6 joint publications

Jaime Sanz